Pesquisas alternativas:
comps » comes (Expandir a Pesquisa), camps (Expandir a Pesquisa), combs (Expandir a Pesquisa)
neto » net (Expandir a Pesquisa)
completed » complete (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)
comor » comorb (Expandir a Pesquisa), comer (Expandir a Pesquisa), compr (Expandir a Pesquisa)
comps » comes (Expandir a Pesquisa), camps (Expandir a Pesquisa), combs (Expandir a Pesquisa)
neto » net (Expandir a Pesquisa)
completed » complete (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)
comor » comorb (Expandir a Pesquisa), comer (Expandir a Pesquisa), compr (Expandir a Pesquisa)
101
Por Marquis, P, Lasch, K E, Delgado-Herrera, L, Kothari, S, Lembo, A, Lademacher, C, Spears, G, Nishida, A, Tesler, Waldman L, Piault, E, Rosa, K, Zeiher, B
Publicado em 2014
“... in five study phases: (1) eight concept elicitation focus groups (N=34), from which a 17-item IBS-D Daily...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
102
Por Segawa, Y, Ueoka, H, Kiura, K, Kamei, H, Tabata, M, Sakae, K, Hiraki, Y, Kawahara, S, Eguchi, K, Hiraki, S, Harada for the Okayama Lung Cancer Study Group, Mine
Publicado em 2000
“... is associated with a survival advantage for selected patients with locally advanced unresectable non-small-cell...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
103
Por Turner, R. Scott, Thomas, Ronald G., Craft, Suzanne, van Dyck, Christopher H., Mintzer, Jacobo, Reynolds, Brigid A., Brewer, James B., Rissman, Robert A., Raman, Rema, Aisen, Paul S.
Publicado no Neurology (2015)
“...OBJECTIVE: A randomized, placebo-controlled, double-blind, multicenter 52-week phase 2 trial...”Publicado no Neurology (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
104
Por Cooper, BW, Kindwall-Keller, TL, Craig, MD, Creger, RJ, Hamadani, M, Tse, WW, Lazarus, HM
Publicado no Clin Lymphoma Myeloma Leuk (2015)
“...BACKGROUND: Midostaurin is a novel, orally available FLT3 tyrosine kinase inhibitor that induces...”Publicado no Clin Lymphoma Myeloma Leuk (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
105
“...Studies from throughout much of the world have shown a general increase in extreme precipitation...”
Obter o texto integral
Obter o texto integral
Artigo
106
Por Cheng, Karis Kin Fong, Ip, Wan Yim, Lee, Vincent, Li, Chak Ho, Yuen, Hui Leung, Epstein, Joel B.
Publicado no Asia Pac J Oncol Nurs (2017)
“.... METHODS: This was part of a multicenter, prospective cohort study involving two phases. Phase I involved...”Publicado no Asia Pac J Oncol Nurs (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
107
Por Simon, Sonu Kalappurakkal, Pavithran, Praveen Valliyaparambil, Asirvatham, Aldyne Reena, Ayyadurai, R., Parasuram, A.
Publicado no Indian J Endocrinol Metab (2018)
“... of these disorders. MATERIALS AND METHODS: A total of 36 consecutive adult patients who underwent surgery for sellar...”Publicado no Indian J Endocrinol Metab (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
108
Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia
Por Sibai, H., Seki, J.T., Wang, T.Q., Sakurai, N., Atenafu, E.G., Yee, K.W.L., Schuh, A.C., Gupta, V., Minden, M.D., Schimmer, A.D., Brandwein, J.M.
Publicado no Curr Oncol (2016)
“...BACKGROUND: Venous thromboembolism (vte) is a recognized complication in patients treated...”Publicado no Curr Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
109
Por Yang, Jianliang, Shi, Yuankai, Zhang, Xiangru, Xu, Jianping, Wang, Bin, Hao, Xuezhi, Li, Junling, Yan, Wang
Publicado no Thorac Cancer (2014)
“... combined with intercalated gefitinib in patients with advanced, untreated, nonsquamous non-small cell lung...”Publicado no Thorac Cancer (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
110
“... using a randomized complete block, controlled, open label design was conducted at an academic clinical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
111
Por Gauthier, Serge, Feldman, Howard H, Schneider, Lon S, Wilcock, Gordon K, Frisoni, Giovanni B, Hardlund, Jiri H, Moebius, Hans J, Bentham, Peter, Kook, Karin A, Wischik, Damon J, Schelter, Bjoern O, Davis, Charles S, Staff, Roger T, Bracoud, Luc, Shamsi, Kohkan, Storey, John M D, Harrington, Charles R, Wischik, Claude M
Publicado no Lancet (2016)
“... assigned participants (3:3:4) to 75 mg LMTM twice a day, 125 mg LMTM twice a day, or control (4 mg LMTM...”Publicado no Lancet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
112
Por Schmiedeberg-Sohn, Anke, Graessel, Elmar, Luttenberger, Katharina
Publicado no Dement Geriatr Cogn Dis Extra (2015)
“... activities of daily living. These measures frequently require a long time to administer, are strongly...”Publicado no Dement Geriatr Cogn Dis Extra (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
113
Por Walsh, Sharon L., Comer, Sandra D., Lofwall, Michelle R., Vince, Bradley, Levy-Cooperman, Naama, Kelsh, Debra, Coe, Marion A., Jones, Jermaine D., Nuzzo, Paul A., Tiberg, Fredrik, Sheldon, Behshad, Kim, Sonnie
Publicado no JAMA Psychiatry (2017)
“..., 2015 (first patient enrolled), to April 21, 2016 (last patient visit). INTERVENTIONS: A total of five 3...”Publicado no JAMA Psychiatry (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
114
Por Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Liu, Qing, Robidoux, André, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Paik, Soonmyung, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman
Publicado no Lancet Oncol (2015)
“...BACKGROUND: NSABP B-40 was a 3 × 2 factorial trial testing whether adding capecitabine...”Publicado no Lancet Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
115
Por Durgam, Suresh, Landbloom, Ronald P, Mackle, Mary, Wu, Xiao, Mathews, Maju, Nasrallah, Henry A
Publicado no Neuropsychiatr Dis Treat (2017)
“... completed a 6-week randomized, double-blind, placebo- and olanzapine-controlled study continued lead...”Publicado no Neuropsychiatr Dis Treat (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
116
“...), due to a longer duration of phase II. Non-propagated and retrogradely propagated phase III activity...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
117
Por West, Howard L., Moon, James, Wozniak, Antoinette J., Mack, Philip, Hirsch, Fred R., Bury, Martin J., Kwong, Myron, Nguyen, Dorothy D., Moore, Dennis F., Miao, Jieling, Redman, Mary, Kelly, Karen, Gandara, David R.
Publicado no Clin Lung Cancer (2017)
“... with a combination of an EGFR TKI with the anti-angiogenic agent bevacizumab, SWOG initiated paired phase...”Publicado no Clin Lung Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
118
Por Karp, Daniel D., Lee, Sandra J., Keller, Steven M., Wright, Gail Shaw, Aisner, Seena, Belinsky, Steven Alan, Johnson, David H., Johnston, Michael R., Goodman, Gary, Clamon, Gerald, Okawara, Gordon, Marks, Randolph, Frechette, Eric, McCaskill-Stevens, Worta, Lippman, Scott M., Ruckdeschel, John, Khuri, Fadlo R.
Publicado em 2013
“...PURPOSE: Selenium has been reported to have chemopreventive benefits in lung cancer. We conducted a...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
119
Por Lodise, Thomas P., Redell, Mark, Armstrong, Shannon O., Sulham, Katherine A., Corey, G. Ralph
Publicado no Open Forum Infect Dis (2017)
“... received treatment in the outpatient setting in the Phase 3 SOLO clinical trials. METHODS: SOLO I and SOLO...”Publicado no Open Forum Infect Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
120
Por Kim, Sung-Hyun, Menon, Hari, Jootar, Saengsuree, Saikia, Tapan, Kwak, Jae-Yong, Sohn, Sang-Kyun, Park, Joon Seong, Jeong, Seong Hyun, Kim, Hyeoung Joon, Kim, Yeo-Kyeoung, Oh, Suk Joong, Kim, Hawk, Zang, Dae Young, Chung, Joo Seop, Shin, Ho Jin, Do, Young Rok, Kim, Jeong-A, Kim, Dae-Young, Choi, Chul Won, Park, Sahee, Park, Hye Lin, Lee, Gong Yeal, Cho, Dae Jin, Shin, Jae Soo, Kim, Dong-Wook
Publicado em 2014
“... radotinib 400 mg twice daily for 12 cycles based on results from the phase I trial. The primary end point...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo